The UK government starts a trial offering weight loss drug Mounjaro to unemployed obese individuals to improve health and workforce reentry. The initiative is part of a five-year NHS strategy. Eli Lilly commits £279 million to address Britain’s health challenges, with Mounjaro showing significant weight loss benefits.UK’s weight loss jab Mounjaro might help people get back to work
The UK government starts a trial offering weight loss drug Mounjaro to unemployed obese individuals to improve health and workforce reentry. The initiative is part of a five-year NHS strategy. Eli Lilly commits £279 million to address Britain’s health challenges, with Mounjaro showing significant weight loss benefits.
